DENTAL CARE IMPROVEMENTS USING INFORMATICS AND ARTIFICIAL INTELLIGENCE
Professor Heiko Spallek
Head of School and Dean of The University of Sydney School of Dentistry &
Member of Scientific Advisory Committee, Dentroid
RESEARCHER PROFILE
Filmed in Sydney, Australia | December 2024
Professor Heiko Spallek is the Head of School and Dean of the Sydney Dental School, as well as a member of the Scientific Advisory Committee for Dentroid, a startup in Australia aiming to revolutionise dentistry with laser technology. He has gained extensive experience in various roles at research-intensive institutions across three different continents.
Professor Spallek advanced his dental knowledge by studying computer information science in the US, particularly in Philadelphia. He conducted research for 20 years in the US at the intersection of dentistry and informatics.
As the Dean of Dentistry, he remains involved with a group in the US focused on improving dental care through informatics and artificial intelligence. In Australia, he finds the opportunity to work with Dentroid particularly engaging, as the startup seeks to enhance dental care by eliminating needles and drills to reduce patient discomfort.
Professor Spallek notes that there haven’t been significant changes in dentistry over the past few decades, aside from incremental improvements. He finds it both challenging and interesting to address the stagnation in the field, despite the availability of better materials in dentistry.
He points out that traditional dental treatments still heavily rely on local anaesthesia administered through long needles, as well as high-pitched noises and vibrations from hand pieces, which create discomfort for patients. Furthermore, dentists often have to hunch over patients’ mouths, exposing themselves to infectious spray.
Dentroid is attempting to create a paradigm shift by starting treatments with a light-induced analgesic, followed by a small robot that clamps onto the tooth, removing tissue without the need for drilling through laser technology. This procedure is guided and controlled by the dentist from a desk. Professor Spallek collaborates with researchers from four leading institutions in Australia to bring this new vision to life.
Outside of his professional responsibilities, Professor Spallek prioritises his family and serves as a volunteer director for Community Connections Australia. This organisation offers a range of tailored services to individuals living with disabilities. With the support of a management team, their 150 frontline workers assist approximately 300 clients in achieving greater independence in their homes.
-
Novel therapies & next-gen medical devices in cardiovascular & vascular disease management
Professor Shirley Jansen AM is a distinguished vascular and endovascular surgeon whose career spans clinical leadership, academic excellence, and pioneering research. She currently holds the Lawrence-Brown Chair of Vascular Surgery at Curtin University’s School of Population Health and serves as Head of the Department of Vascular Surgery at Sir Charles Gairdner Hospital, a role she has held since 2015. In addition, she is the Director of the Heart & Vascular Research Institute at the Harry Perkins Institute for Medical Research. Her early career was marked by prestigious fellowships, including a British Heart Foundation Research Fellowship (1996), and multiple international travelling fellowships from leading surgical societies and industry sponsors between 2001 and 2002.
-
Good and bad extracellular vesicles in health and disease
Associate Professor Joy Wolfram has joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, and through her work at the AIBN, she aims to develop a new paradigm of therapeutics (using nanotechnology and cell products) to treat life-threatening diseases that are major causes of death globally, including cardiovascular disease, kidney disease, and breast cancer.
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
